The rumors of an acquisition of Auris Health Inc. by New Brunswick, N.J.-based Johnson & Johnson (J&J) have been around for a few weeks, since right around the latter's annual earnings report on Jan. 22. Now the conglomerate has confirmed that its Ethicon Inc. subsidiary will acquire Redwood City, Calif.-based Auris for $3.4 billion in cash and up to an additional $2.35 billion in undisclosed milestones.
Edwards Lifesciences Corp. will acquire micro-cap Cas Medical Systems Inc. (Casmed) for about $100 million. The pair were partnered already on 510(k) clearance-pending cable and software to connect Casmed's Fore-Sight brain tissue oxygenation monitor to Edwards' Hemosphere hemodynamic monitoring platform for surgery and critical care.
RSS